What is the exact mechanism of synthetic agents showed the cell cycle arrest in G0/G1 and G2/M2 phase in flow cytometry analysis.
Synthetic agents can induce cell cycle arrest in G0/G1 and G2/M phases through various mechanisms. Here's a breakdown of the key mechanisms and how they affect cell cycle progression:
G0/G1 Arrest Mechanisms:
- Cyclin-dependent kinase (CDK) inhibition: Many synthetic agents target CDKs, which are protein kinases essential for driving cell cycle progression. By inhibiting CDKs, these agents prevent phosphorylation of critical proteins involved in the G1/S phase transition, leading to G0/G1 arrest. Examples include:CDK4/6 inhibitors: These drugs target CDK4 and CDK6, which phosphorylate Rb protein. Unphosphorylated Rb prevents E2F transcription factors from driving S phase entry, causing G0/G1 arrest.
- DNA damage response: DNA damaging agents (e.g., chemotherapy drugs) activate a cellular checkpoint in G1. This checkpoint halts the cell cycle and allows for DNA repair before proceeding to S phase. If the damage is extensive, the cell might undergo apoptosis (programmed cell death).
G2/M Arrest Mechanisms:
- DNA damage checkpoint: Similar to G1 arrest, DNA damage can trigger a checkpoint in G2. This prevents cells from entering mitosis with damaged DNA, which could lead to mutations.
- Spindle assembly checkpoint: This checkpoint ensures proper attachment of microtubules to chromosomes before mitosis. If the spindle assembly is incomplete, the checkpoint enforces G2/M arrest until correct attachment occurs.
- Inhibition of key mitotic regulators: Certain drugs target proteins essential for mitosis, such as Aurora kinases or Eg5. This disrupts spindle formation or chromosome segregation, leading to G2/M arrest.
Flow Cytometry Analysis:
Flow cytometry analysis uses fluorescent dyes to measure DNA content in cells. By analyzing the distribution of cells based on DNA content, researchers can identify cell cycle phases:
- G0/G1: Cells have a single copy of their DNA and appear as a peak at a lower fluorescence intensity.
- S Phase: Cells are replicating their DNA and show increased fluorescence intensity compared to G0/G1.
- G2/M: Cells have completed DNA replication and have double the amount of DNA, resulting in a peak at the highest fluorescence intensity.
When a synthetic agent induces cell cycle arrest, the proportion of cells in a specific phase (G0/G1 or G2/M) increases in the flow cytometry analysis, indicating a block in cell cycle progression.
Additional Notes:
- The specific mechanism of action for a synthetic agent will determine the predominant cell cycle phase affected (G0/G1 or G2/M).
- Some agents might have pleiotropic effects, meaning they can target multiple cell cycle checkpoints leading to arrest in both G0/G1 and G2/M phases.
Hello Prasad,
Among the hallmarks of cancer cells are the aberrant cell cycle and apoptosis regulation. Cancer cells are known to lose the ability to negatively regulate the cell cycle leading to their continuous proliferation and resist apoptosis even in the presence of an apoptotic stimuli.
Anti-cancer agents exhibit anticancer activity by targeting several signaling cascades associated with cell cycle regulation and apoptosis. These cascades include mitogenic signaling pathways, such as mitogen-activated protein kinases (MAPKs), PI3K-Akt pathway and nuclear kappa B pathway (NF-kB).
For G0/G1 arrest, you may measure the change in the regulatory proteins of the cell cycle such as cyclins (D1 and E), CDK (CDK2 and CDK4), p21WAF1/CIP1 and p-Rb at the G0/G1 phase by immunoblot analysis. You may find decreased levels of cyclins and p-Rb, depending on the dose of anti-cancer agent. Furthermore, when the cell cycle is arrested in the G0/G1 phase, the cells are likely to activate one of the pathways namely, apoptosis, necrosis, or differentiation. As the cancer cells cannot activate the differentiation mechanism, they will choose either apoptosis or necrosis. So, by using specific apoptotic and necrotic stains such as acridine orange (AO) and ethidium bromide (EB), you may be able to confirm the pathway that has been chosen. Alternatively, the anti-proliferative activities that occur due to apoptosis, may be carried out by the quantitative assessment of apoptosis determined by Annexin V-FITC/PI staining using flow cytometry.
ROS are involved in multiple signaling cascades of tumor development. Its excessive generation could lead to causing severe harm to DNA and proteins, leading to apoptosis. The anti-cancer agent could induce apoptosis by triggering ROS generation in cancer cells.
Cell cycle arrest at the G2/M phase indicates that the damage of intracellular DNA is difficult to repair. Studies have shown that the ATM/ATR signaling pathway is activated when intracellular DNA is damaged and can repair damaged DNA by regulating the activity of many proteins. ATM protein is activated during DNA damage, which subsequently upregulates the expression of checkpoint kinase 2 (Chk2) protein and increases the phosphorylation of Chk2 and cell division cycle 25C (CDC25C). Chk2-mediated phosphorylation of Cdc25C plays a major role in irreversible G2/M arrest. Meanwhile, the decrease in the content of the CDK 1/cyclin B complex by inhibiting the levels of CDK1 and cyclin B can subsequently induce cell cycle arrest at the G2/M phase.
Numerous anti-cancer agents have the potential to induce G2/M phase arrest by targeting the cyclin B1/CDK1 complex. Moreover, there have been studies indicating that p21 plays a critical role in blocking CDK1/cyclin B1 activation in a p53-dependent or independent manner. By immunoblot analysis, you may find decreased expression of Cyclin B1, CDK1, and up-regulation of p21, p27, and phospho-Cdc25.
You may want to refer to the article attached below for more information.
https://doi.org/10.1172/JCI9054
Best.
- Badges
- Science topic
- Similar topics
- Filing